Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 08:00 ET | Source: Step Pharma

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to more than 20 regulatory approvals Dr Smith's appointment will accelerate Step...
October 21, 2025 10:24 ET | Source: Step Pharma

Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer,...
October 21, 2025 03:00 ET | Source: Step Pharma

Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer,...
October 15, 2025 08:00 ET | Source: Step Pharma

Step Pharma announces completion of €38 million Series C financing

Financing will support the Company’s ongoing clinical development of its lead asset, dencatistat, across multiple indicationsRound led by new investor V-Bio Ventures, with participation from existing...
September 02, 2025 08:00 ET | Source: Step Pharma

Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia

Start of the phase 1b trial in a new indication expands Step Pharma’s clinical programme, building on the development of dencatistat in lymphoma and solid tumoursThis milestone marks the third...